Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215741 · ClinicalTrials.gov registry record
Retrospective, Multi-center Real-world Study of StimLabs Human Placental Membrane Tissue to Treat Hard-to-Heal Wounds
A clinical trial of Chronic Wounds and Diabetic Ulcers, sponsored by StimLabs.
- Active
- Registry status
- 50
- Enrollment target
- 3
- Study locations
NCT07215741 is a study of Chronic Wounds and Diabetic Ulcers that is active but no longer recruiting, run by StimLabs. The registered enrollment target is 50 participants, below the 173-participant average among 4 other Chronic Wounds trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT07215741, a study of Chronic Wounds and Diabetic Ulcers, is active but no longer recruiting, sponsored by StimLabs.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a retrospective, multi-center observational study to assess real-world outcomes of StimLabs human placental membrane tissue used in the treatment of hard-to-heal wounds, including chronic ulcers, diabetic foot ulcers (DFUs), and venous leg ulcers (VLUs). The collection of retrospective real-world data provides a broad range of experiences related to patient healthcare and treatment.
Conditions Studied
Study Locations (3)
Texas
- Premier Foot & Ankle - Denison
- Premier Foot & Ankle - Frisco
Oklahoma
- Cypress Wound Care - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07215741
The ClinicalTrials.gov registry entry for NCT07215741 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 173-participant average among 4 other Chronic Wounds trials with a reported enrollment target (71% lower). The listed sponsor is StimLabs, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Wounds appearing as the primary indexed condition, and to 0 interventions.
NCT07215741 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Texas, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT07215741 about?
NCT07215741 is a clinical study titled "Retrospective, Multi-center Real-world Study of StimLabs Human Placental Membrane Tissue to Treat Hard-to-Heal Wounds". This is a retrospective, multi-center observational study to assess real-world outcomes of StimLabs human placental membrane tissue used in the treatment of hard-to-heal wounds, including chronic ulcers, diabetic foot ulcers (DFUs), and venous leg ulcers (VLUs). The collection of retrospective real-...
What is the current status of trial NCT07215741?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2025-09-01. Estimated completion is 2025-12.
What conditions does trial NCT07215741 study?
This clinical trial studies the following conditions: Chronic Wounds, Diabetic Ulcers.
Who is sponsoring clinical trial NCT07215741?
This trial is sponsored by StimLabs, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07215741 being conducted?
This trial has 3 study locations across Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Wounds
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.